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program to implement latent tuberculosis infection (LTBI)
treatment for TB contacts. Child contacts aged younger
than 13 years were the first priority group to receiveTable 1 Definitions of the period of infectiousness in TB cases. (Guide
persons with tuberculosis, by index case characteristic; revised and trans
cdc.gov.tw/public/Attachment/04199462271.doc).
Characteristic
TB symptoms AFB sputum positive Cavitary chest radiograph o
Mycobacterium tuberculosis
culture positive
Yes Yes Yes
No Yes Yes
Yes Yes No
Yes No Yes
No Yes No
No No Yes
Yes No No
No No No
AFB Z Acid-fast bacilli; TB Z tuberculosis.
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doi:10.1016/j.jfma.2011.11.001treatment. Countries in West-Pacific and South-Eastern
Asia, such as Japan, Hong Kong, and South Korea have
scaled up their LTBI strategies in recent years in order to
reach the long-term goal of stopping TB.1e3 Incidence of TBlines for estimating the beginning of the period of infectiousness of
lated from Chapter 6, Manual for TB Control in Taiwan, http://www.
Recommended minimum beginning of likely period of
infectiousness
r
3 mo before symptom onset or first positive finding consistent
with TB disease, whichever is longer
3 mo before first positive finding consistent with TB
3 mo before symptom onset or first positive finding consistent
with TB disease, whichever is longer
3 mo before symptom onset or first positive finding consistent
with TB disease, whichever is longer
3 mo before first positive finding consistent with TB
3 mo before first positive finding consistent with TB
1 mo before symptom onset or first positive finding
(e.g., abnormal chest radiograph) consistent with TB disease,
whichever is longer
1 mo before date of suspected diagnosis
& Formosan Medical Association. All rights reserved.
Figure 1 Illustration of how to estimate the beginning of the period of infectiousness of persons with tuberculosis, by index case
characteristics. AFB Z Acid-fast bacilli; TB Z tuberculosis.
Table 2 Examination schedule for TB contacts. (Revised and translated from Appendix 6-1 from Manual for TB Control in Taiwan, http://www.
cdc.gov.tw/public/Attachment/03111034771.doc).
Timing/age/methods Index condition/agea
Positive for either sputum
AFB or culture, or cavitation
on the chest radiograph
(index cases aged 5 years
and oldera)
Negative for sputum AFB
and culture, without
cavitation on the chest
radiograph (index cases
aged 5 years and oldera)
index cases
aged <5 yearsa þ
extrapulmonary TB without
lung involvement
(all age index cases)
Within 1 month after
TB diagnosis
of index cases
confirmed
CXR for contacts aged
13 years and older
B B B
CXR and TST for contacts
aged <13 years
B B Note 1b: CXR only,
no need to do TST
B Note 2: CXR only,
no need to do TST
The 3rd month 2nd TST for contacts
aged <13 years who
had negative result
of 1st TST
B ㄨ ㄨ
The 12th month
(1 month)
2nd CXR for contacts
aged 13 years B ㄨ ㄨ
2nd CXR for contacts
aged <13 years
B Note 3: the contacts
with negative
result of 2nd TST can
waive the 2nd CXR if
their index cases are
regularly treated
ㄨb ㄨ
AFB Z Acid-fast bacilli; CXR Z chest radiograph; MDRTB Z multi-drug resistance TB; TST Z tuberculin skin test.
Special conditions:
1. Contacts for MDRTB cases: public health nurses should remind contacts to complete CXR before the end of the first month after notification of
MDRTB; contacts should receive CXR every 6 months for 2 years.
2. Contacts for chronic TB cases: annual CXR.
3. If contacts are pregnant, sputum for AFB/mycobacterial culture will be checked if contacts can provide sputum. When pregnant contacts have
respiratory symptoms, CXR could be performed to rule out active TB and avoid delay to diagnosis.
a Currently, age of index cases are not considered and there is no difference in contact investigation methods for their contacts. The rec-
ommended criteria for index cases will be implemented in 2012 as shown in this table.
b Currently, contacts<13 years, whose index cases with negative for sputum AFB and culture without cavitation on the chest radiograph received
oneTSTwithinonemonthafter TBdiagnosis of indexcases is confirmed.Thesecontacts receivedonlyCXRat 1year after last exposure to index case if
they had positive result of TST. The recommended method for contact investigation will be implemented in 2012 as shown in this table.
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Perspectives 735in Taiwan decreased gradually from 73/100,000 in 2005 to
57/100,000 in 2010.4 With decreasing TB case number, and
decreasing mortality rate under the directly observed
treatment (DOT) strategy, diagnosis and treatment of LTBI
in high-risk populations has become the most important
strategy for case management.
The sensitivity and specificity of the tuberculin skin test
(TST) in identifying Mycobacterium tuberculosis (MTB)
infection has been found to be less than optimal in a pop-
ulation with prior Bacillus Calmette-Gue´rin (BCG) vaccina-
tion, probably due to antigenic cross-reactivity between
purified protein derivative from repeated or recent BCG
and environmental mycobacteria.5 In Taiwan, the BCG
booster program for 6th grade students was stopped in
1997.6 Therefore, young people who were born after
January 1st, 1986 received only one BCG vaccination, at
birth. As a result, the TST was still useful in identifying
these adolescent and young adult contacts eligible for LTBI
treatment in Taiwan. Several studies revealed that IFN-g
release assays (IGRAs) could provide higher specificity than
the TST in BCG-vaccinated populations. However, IGRAs
could probably offer higher sensitivity than the TST in
elderly or immunocompromised populations with waning or
poor T cell response.7,8Figure 2 The flow chart for latent tuberculosis infection treatme
TB Control in Taiwan, http://www.cdc.gov.tw/public/Attachm
CXR Z chest radiography; LTBI Z latent tuberculosis infecti
TST Z tuberculin skin test. Data have been obtained from: Chapt
edition. http://www.cdc.gov.tw/public/Attachment/13241346297
www.cdc.gov.tw/public/Attachment/0219495471.pdf; Chapter 8, TIsoniazid monotherapy for LTBI treatment is still the
standard drug of choice for LTBI treatment. A recently
introduced alternative regimen for LTBI is 12 doses of
once weekly rifapentine (900 mg) plus isoniazid (900 mg).
Optimistic preliminary results were reported in adults
with low prevalence of human immunodeficiency virus
(HIV) infection who were randomized to receive 12 doses
of rifapentine regimen and 9 months of isoniazid.9 In
a trial conducted in South Africa where the prevalence of
TB was very high, all regimens including a 3-month course
of intermittent rifapentine or rifampin with isoniazid, and
continuous isoniazid were not superior to 6 months of
isoniazid in HIV patients.10 No resistance to rifampin was
observed among the 58 strains collected in patients with
active TB during the 4000 person-year follow-up. Patients
in the continuous-isoniazid group had a 58% lower rate of
TB or death than those receiving the 6-month control
regimen of isoniazid, but the rates of TB in the
continuous-isoniazid group markedly increased when
therapy was discontinued. Shorter, intermittent,
rifapentine-based LTBI treatment with a stringent DOT
strategy could provide the most benefits when provided to
patients in rural area where DOT is labor intensive and
costly.nt. (Revised and translated from appendix 14-2 from Manual for
ent/03111034771.doc). AP view Z anteroposterior view;
on; PA view Z posteroanterior view; TB Z tuberculosis;
er 10, Taiwan Guidelines for TB Diagnosis and Treatment, 4th
1.pdf; Chapter 14, Manual for TB Control in Taiwan, http://
aiwan Guidelines for TB Diagnosis and Treatment, 4th edition.
736 P.-C. Chan et al.Table 1 shows how the period of infectiousness in TB
cases can be determined by public health workers investi-
gating TB contact in Taiwan. The beginning of the period of
infectiousness of TB cases depends on four characteristics
of the index TB patients: presenting symptoms of TB;
positive for acid-fast bacilli in the sputum; findings of the
chest radiograph; and positive for MTB culture. Fig. 1
illustrates the timeline for the start of infectiousness, TB
symptoms, and abnormalities of either chest radiography or
sputum examination. The end of infectiousness is on the
day of submission of a sputum culture that later turns
negative. Contacts are identified according to infectious
period and a time of exposure to the index case of up to
eight hours/day or an accumulative 40 hours. Public health
nurses should start preliminary contact investigation after
TB diagnosis of index cases is confirmed. Within 1 month,
the index TB case should be interviewed, their contacts
identified and TB screening provided to every identified
contact according to the age and contagiousness of index
cases and age of contacts (Table 2). Contacts of index cases
with positive sputum and cavitation on the chest radiograph
need evaluation and either 12-month follow-up or LTBI
evaluation according to their age. Contacts receive only
one chest radiograph without evaluation of LTBI if index
cases are younger than 5 years (all forms), have extrap-
ulmonary TB without lung involvement, or have negative
sputum and no cavitation on the chest radiograph. The
algorithm of diagnosis and treatment of LTBI is shown in
Fig. 2.
In conclusion, it is the time to consider wider imple-
mentation of LTBI treatment in Taiwan, especially for
adolescents with a history of close contact with infectious
TB. The slogan of World TB Day in 2012 is “Stop TB in My
Lifetime”; using the most cost-efficient strategy to identify
LTBI cases and providing treatment through an effective
delivery system may help Taiwan to contribute to a world
free of TB.References
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